8-K ·Filed Feb 25, 2026

A

AGILENT TECHNOLOGIES, INC.
BULLISH
Impact 7/10
Horizonweeks Processed7mo ago SEC0001090872-26-000015
8-K Item 2.02: Earnings release
Actionable Insight ▲ Bullish

The combination of raised guidance, solid core revenue growth, and margin expansion suggests resilient demand. Traders should monitor CrossLab Group performance as a key growth driver and watch for continued margin improvements in upcoming quarters.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
A ▼ -8.69% at T+60d
LONG call ✗ call lost -8.69% · α vs SPY -15.64% · entry $124.61 → $113.78
Entry anchored
Feb 24, 03:59 PM ET
via exchange tick
T+1d
-2.99%
call -2.99% · α -2.45%
$120.88
settled 7mo ago
T+5d
-3.32%
call -3.32% · α -2.22%
$120.47
settled 7mo ago
T+20d
-9.37%
call -9.37% · α -4.14%
$112.93
settled 6mo ago
T+60d
-8.69%
call -8.69% · α -15.64%
$113.78
settled 5mo ago

Price Chart

Loading chart...

Executive Summary

Agilent Technologies reported solid Q1 FY2026 results with $1.80 billion in revenue, up 7.0% year-over-year, and raised its full-year revenue outlook. Non-GAAP EPS of $1.36 grew 4% YoY. The company increased its non-GAAP EPS guidance for favorable currency impacts while maintaining core growth and margin expansion targets.

Key Financial Metrics

Revenue
$1.8B
+7.0% YoY
Adj. EPS
$1.36
GAAP: $1.07
Guidance
$7.3B-$7.5B
raised

Key Facts

  • Q1 revenue of $1.80 billion, up 7.0% reported and 4.4% on a core basis YoY
  • GAAP EPS of $1.07, down 4% YoY; non-GAAP EPS of $1.36, up 4% YoY
  • Raised full-year revenue outlook to $7.3B-$7.5B (5.5%-7.5% growth) and increased non-GAAP EPS guidance to $5.90-$6.04
  • Agilent CrossLab Group drove growth with 9% reported revenue increase
  • Company cites strong instrument-replacement cycle and Enterprise Services engagement as key drivers

Financial Impact

Revenue growth of 7.0% ($1.80B) with improved full-year guidance and increased non-GAAP EPS outlook

revenueepsguidance

Segment Breakdown

SegmentRevenueGrowth
Life Sciences and Diagnostics Markets Group$679.0M+5.0%
Agilent CrossLab Group$758.0M+9.0%
Applied Markets Group$361.0M+7.0%

Risk Factors

  • GAAP net income declined 4% YoY despite revenue growth
  • Operating margins declined across all segments compared to prior year
  • Forward guidance based on forecasted currency exchange rates which could change

Market Snapshot

Exchange
NYSE

Investment Themes

Industrials & Manufacturing

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001090872-26-000015
Document: a-20260225.htm0001090872-26-000015
Document: 0001090872-26-000015-index-headers.html0001090872-26-000015
Document: 0001090872-26-000015-index.html0001090872-26-000015
Document: 0001090872-26-000015.txt0001090872-26-000015
6 reports for A
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for A — sortable, filterable
TypeNow
Aug 1, 2026
8w ago
Institutional Cluster
MIXED ★ 4/10
$139.80 $153.56▲ +9.84%▲ +8.60%$168.41 (+20.47%)
Jun 25, 2026
14w ago
8-K
NEUTRAL ★ 4/10
$136.01 $139.74▲ +2.74%▲ +1.48%$168.41 (+23.83%)
May 27, 2026
18w ago
8-K
BULLISH ★ 7/10
$135.31 $135.51▲ +0.15%▲ +2.84%$168.41 (+24.47%)
May 4, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$112.10 $135.98▲ +21.31%▲ +15.66%$168.41 (+50.24%)
Apr 3, 2026
25w ago
8-K
NEUTRAL ★ 3/10
$114.84 $112.10▼ −2.39%▼ −11.37%$168.41 (+46.65%)
Feb 25, 2026
31w ago
8-K
BULLISH ★ 7/10
$124.61 $112.93▼ −9.37%▼ −4.14%$168.41 (+35.16%)
Showing 6 of 6

US Market Status

Market Open — Closes in 5h 24m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access